Citadel Securities maintains an 'Add' on Shire (SHPGY); Strong HGT, Specialty Growth Continues; Raising PT
Get Alerts SHPGY Hot Sheet
Price: $85.67 -0.2%
Rating Summary:
8 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 19
Rating Summary:
8 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 19
Join SI Premium – FREE
Citadel Securities maintains an 'Add' on Shire plc (NASDAQ: SHPGY) price target raised from $97 to $120.
Citadel analyst says, "We are raising our price target to $120 based on expectations for higher revenue growth and margin expansion during 2011 and 2012. Our 2012 revenues estimate increases to $4,292MM from $4,171MM, and 2012 increases to $4,868MM from $4,840MM, driven by higher revenue contribution from the ADHD and HGT franchises. Our 2011 adjusted EPS estimate increases to $5.13 from $5.08, and 2012 increases to $6.09 from $5.93."
For more ratings news on Shire plc click here and for the rating history of Shire plc click here.
Shares of Shire plc closed at $99.25 yesterday.
Citadel analyst says, "We are raising our price target to $120 based on expectations for higher revenue growth and margin expansion during 2011 and 2012. Our 2012 revenues estimate increases to $4,292MM from $4,171MM, and 2012 increases to $4,868MM from $4,840MM, driven by higher revenue contribution from the ADHD and HGT franchises. Our 2011 adjusted EPS estimate increases to $5.13 from $5.08, and 2012 increases to $6.09 from $5.93."
For more ratings news on Shire plc click here and for the rating history of Shire plc click here.
Shares of Shire plc closed at $99.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades Workday (WDAY) to Hold
- Yesway Inc (YSWY) PT Raised to $32 at Guggenheim
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share